✦ LIBER ✦

Injectable therapy in T2DM: real-world outcomes and costs

Book ID: 121561939
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2014
Weight: 199 KB
Volume: 695
Category: Article
ISSN: 1173-5503
DOI: 10.1007/s40274-014-0999-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

What is the real world for analyzing out

What is the real world for analyzing outcomes and costs of ICD therapy?

✍ Moss, Arthur J. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 46 KB

The INITIATOR Study: Pilot Data on Real-

The INITIATOR Study: Pilot Data on Real-World Clinical and Economic Outcomes in US Patients with Type 2 Diabetes Initiating Injectable Therapy

✍ Thayer, Sarah; Wei, Wenhui; Buysman, Erin; Brekke, Lee; Crown, William; Grabner, 📂 Article 📅 2013 🏛 Springer Healthcare Communications 🌐 English ⚖ 568 KB

PDB1 Real-World Incidence of Hypoglycemi

PDB1 Real-World Incidence of Hypoglycemia and Associated Costs Among Insulin Glargine-Treated Patients With Type 2 Diabetes Mellitus (T2DM)

✍ Xie, L.; Wei, W.; Pan, C.; Baser, O. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Losartan leads to lower costs in T2DM an

Losartan leads to lower costs in T2DM and nephropathy

📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl ⚖ 137 KB

PDB6 Real-World Comparative Effectivenes

PDB6 Real-World Comparative Effectiveness Analysis of Patients Initiating Injectable Treatments for Type 2 Diabetes Mellitus (T2DM): Pilot Data From the Initiator Study

✍ Grabner, M.; Wei, W.; Raparla, S.; Quimbo, R.A.; Cziraky, M.J.; Thayer, S.W.; Br 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PDB32 COST-EFFECTIVENESS CONSEQUENCES OF

PDB32 COST-EFFECTIVENESS CONSEQUENCES OF OBESITY IN T2DM BY INSULIN ANALOGUE THERAPY

✍ Z Józsa; E Tóth; B Nagy 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB